Advanced Solid Tumors Clinical Trials in Santa Monica, California

4 studies are recruiting for advanced solid tumors in Santa Monica, California right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. Phase 1/2 Study of PYX-201 in Combination With Pembrolizumab in Advanced Solid Tumors

    The primary objective of this study is to determine the recommended Phase 2 doses (RP2D(s)) and maximum tolerated dose (MTD) of PYX-201 in combination with pembrolizumab for participants with advanced solid tumors.

    Stage
    Phase 1
    Ages
    18 and older
    Site
    Sarcoma Oncology Center, Santa Monica, California
    Locations
    22 in total
    Run by
    Pyxis Oncology, Inc

    See if you can join NCT06795412 on ClinicalTrials.gov

  2. A Study to Test the Safety and Tolerability of SBO-154 in Patients With Advanced Solid Tumors.

    This is a Phase 1 study of SBO-154 in patients with advanced cancers who are unable to tolerate or have not previously responded to standard therapy available in the country. The study involves multiple doses and takes place at several centers.

    Stage
    Phase 1
    Ages
    18 and older
    Site
    Sarcoma Oncology Research Center, Santa Monica, California
    Locations
    16 in total
    Run by
    Sun Pharma Advanced Research Company Limited

    See if you can join NCT07042100 on ClinicalTrials.gov

  3. Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS

    Evaluate the safety and tolerability of RMC-6236 in adults with specific RAS mutant advanced solid tumors.

    Stage
    Phase 1
    Ages
    18 and older
    Site
    UCLA, Santa Monica, California
    Locations
    21 in total
    Run by
    Revolution Medicines, Inc.

    See if you can join NCT05379985 on ClinicalTrials.gov

  4. A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors

    This is a dose-escalation and dose-expansion Phase 1/2a trial to evaluate the safety and tolerability of DB-1311/BNT324 in subjects with advanced solid tumors.

    Stage
    Phase 1
    Ages
    18 and older
    Site
    Research Site 128, Santa Monica, California
    Locations
    107 in total
    Run by
    DualityBio Inc.

    See if you can join NCT05914116 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.